Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.040
+0.030 (2.95%)
Sep 4, 2026, 9:39 AM EDT - Market open
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $4.14 million as of September 4, 2026. Its market cap has decreased by -10.73% in one year.
Market Cap
4.14M
Enterprise Value
-6.60M
1-Year Change
-10.73%
Ranking
Category
Stock Price
$1.04
ChartMarket Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $4.14M, a decrease of -95.42%. That is a compound annual growth rate of -41.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 4.14M | -12.58% |
| Dec 31, 2025 | 4.74M | 22.99% |
| Dec 31, 2024 | 3.85M | 22.21% |
| Dec 29, 2023 | 3.15M | -29.09% |
| Dec 30, 2022 | 4.45M | -93.24% |
| Dec 31, 2021 | 65.80M | -29.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GRI Bio | 4.37M |
| Alaunos Therapeutics | 4.24M |
| VivoSim Labs | 4.16M |
| PMGC Holdings | 4.12M |
| Mustang Bio | 4.11M |
| GeoVax Labs | 4.07M |
| Silo Pharma | 3.97M |
| Addex Therapeutics | 3.96M |